Log in
Sign up
free
Home
Sectors
Earnings
IPOs
Splits
Example searches
AAPL 10-K FY2019
Visa 10-Q
shopify
renewables AND wind 8-K 6-K NOT TAC
cryptocurrency OR "blockchain technology" OR bitcoin 2018-2021
SELB
Dashboard
SELB
Financials
Financials
Data Charts
Data
Institutional Ownership Data
Ownership
Insider Trades
Insider
Short Interest
Shorts
ESG
ESG
All Filings
Filings
Patents
8-K Filing
8-K
SELB
Selecta Biosciences
8-K
2021
Selecta Biosciences Announces Data in Non-Human Primates, Further Validating Multiple Potential Benefits of the ImmTORTM Platform in Gene Therapy
6 Jan 21
Files
SEC
8-K
Current report
99.1
Selecta Biosciences Announces Data in Non-Human Primates, Further Validating Multiple Potential Benefits of the ImmTORTM Platform in Gene Therapy
Download Excel data file
View Excel data file
Content Analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
SELB 8-K Filings
6 Jan 21
Selecta Biosciences Announces Data in Non-Human Primates, Further Validating Multiple Potential Benefits of the ImmTORTM Platform in Gene Therapy
5 Nov 20
Selecta Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
8 Oct 20
Other Events
30 Sep 20
Results of Operations and Financial Condition
Filing View
Default size
S
M
L
Default font
Times
Arial
Search this filing
Search
All
Tables only
Footnotes only
Pre-defined:
Material
ESG
Footnotes
Table of Contents
Get all this for free
Email alerts for new filings that match keywords or companies
Plot, compare & download financial data
10-K & 10-Q redlined comparisons
Advanced filing search & analysis
Sentiment analysis for financial filings
Favorites, search history, and more…
Sign up for free now
More benefits
Top
SELB